Cellular/JJ
disposition/NN
of/IN
sulphamethoxazole/NN
and/CC
its/PRP$
metabolites/NNS
:/:
implications/NNS
for/IN
hypersensitivity/NN
./.

1./LS
Bioactivation/NN
of/IN
sulphamethoxazole/NN
(/(
SMX/NN
)/)
to/TO
chemically-reactive/JJ
metabolites/NNS
and/CC
subsequent/JJ
protein/NN
conjugation/NN
is/VBZ
thought/VBN
to/TO
be/VB
involved/VBN
in/IN
SMX/NN
hypersensitivity/NN
./.
=====
We/PRP
have/VBP
therefore/RB
examined/VBN
the/DT
cellular/JJ
metabolism/NN
,/,
disposition/NN
and/CC
conjugation/NN
of/IN
SMX/NN
and/CC
its/PRP$
metabolites/NNS
in/FW
vitro/FW
./.
=====
2./FW
Flow/NN
cytometry/NN
revealed/VBD
binding/NN
of/IN
N-hydroxy/NN
(/(
SMX-NHOH/NN
)/)
and/CC
nitroso/NN
(/(
SMX-NO/NN
)/)
metabolites/NNS
of/IN
SMX/NN
,/,
but/CC
not/RB
of/IN
SMX/NN
itself/PRP
,/,
to/TO
the/DT
surface/NN
of/IN
viable/JJ
white/JJ
blood/NN
cells/NNS
./.
=====
Cellular/JJ
haptenation/NN
by/IN
SMX-NO/NN
was/VBD
reduced/VBN
by/IN
exogenous/JJ
glutathione/NN
(/(
GSH/NN
)/)
./.
=====
3./LS
SMX-NHOH/NN
and/CC
SMX-NO/NN
were/VBD
rapidly/RB
reduced/VBN
back/RB
to/TO
the/DT
parent/JJ
compound/NN
by/IN
cysteine/NN
(/(
CYS/NN
)/)
,/,
GSH/NN
,/,
human/JJ
peripheral/JJ
blood/NN
cells/NNS
and/CC
plasma/NN
,/,
suggesting/VBG
that/IN
this/DT
is/VBZ
an/DT
important/JJ
and/CC
ubiquitous/JJ
bioinactivation/NN
mechanism/NN
./.
=====
4./LS
Fluorescence/NN
HPLC/NN
showed/VBD
that/IN
SMX-NHOH/NN
and/CC
SMX-NO/NN
depleted/VBD
CYS/NN
and/CC
GSH/NN
in/IN
buffer/NN
,/,
and/CC
to/TO
a/DT
lesser/JJR
extent/NN
,/,
in/IN
cells/NNS
and/CC
plasma/NN
./.
=====
5./LS
Neutrophil/NN
apoptosis/NN
and/CC
inhibition/NN
of/IN
neutrophil/NN
function/NN
were/VBD
induced/VBN
at/IN
lower/JJR
concentrations/NNS
of/IN
SMX-NHOH/NN
and/CC
SMX-NO/NN
than/IN
those/DT
inducing/VBG
loss/NN
of/IN
membrane/NN
viability/NN
,/,
with/IN
SMX/NN
having/VBG
no/DT
effect/NN
./.
=====
Lymphocytes/NNS
were/VBD
significantly/RB
(/(
P/NN
</JJR
0.05/CD
)/)
more/RBR
sensitive/JJ
to/TO
the/DT
direct/JJ
cytotoxic/JJ
effects/NNS
of/IN
SMX-NO/NN
than/IN
neutrophils/NNS
./.
=====
6./LS
Partitioning/NN
of/IN
SMX-NHOH/NN
into/IN
red/JJ
blood/NN
cells/NNS
was/VBD
significantly/RB
(/(
P/NN
</JJR
0.05/CD
)/)
lower/JJR
than/IN
with/IN
the/DT
hydroxylamine/NN
of/IN
dapsone/NN
./.
=====
7./LS
Our/PRP$
results/NNS
suggest/VBP
that/IN
the/DT
balance/NN
between/IN
oxidation/NN
of/IN
SMX/NN
to/TO
its/PRP$
toxic/JJ
metabolites/NNS
and/CC
their/PRP$
reduction/NN
is/VBZ
an/DT
important/JJ
protective/JJ
cellular/JJ
mechanism/NN
./.
=====
If/IN
an/DT
imbalance/NN
exists/VBZ
,/,
haptenation/NN
of/IN
the/DT
toxic/JJ
metabolites/NNS
to/TO
bodily/JJ
proteins/NNS
including/VBG
the/DT
surface/NN
of/IN
viable/JJ
cells/NNS
can/MD
occur/VB
,/,
and/CC
may/MD
result/VB
in/IN
drug/NN
hypersensitivity/NN
./.